IP Library › Assignment 047539/0082
Patent Assignment
Reel/Frame 047539/0082

Assignment of Assignor's Interest

Recorded: 2018-11-19 Pages: 8
Assignor
OCULARIS PHARMA, INC.
Executed: 2010-01-08
Assignee
OCULARIS PHARMA, LLC
2436 SOUTH 6TH AVENUE, NORTH RIVERSIDE, ILLINOIS, 60546-1242
Covered Properties (4)
Method for optimizing pupil size using alpha antagonist
Patent: 6,291,498 →
Application: 09/662,945 →
Night Vision Composition
Patent: 6,730,065 →
Application: 09/675,988 →
Ophthalmic Formulation Which Modulates Dilation
Patent: 6,420,407 →
Application: 09/710,758 →
Ophthalmic Formulation Which Modulates Dilation
Patent: 6,515,006 →
Application: 10/165,459 →
Publication: US 2002/0187986
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 3, 2002
From: HORN, GERALD
To: HMT PHARMA, INC.
Reel/Frame 013250/0043 →
Change of Name Mar 25, 2003
From: HORN, GERALD
To: OCULARIS PHARMA, INC.
Reel/Frame 013894/0887 →
Merger Nov 20, 2018
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 047555/0568 →